Simpson Robert Arthur 4
4 · ANGIODYNAMICS INC · Filed Jul 28, 2017
Insider Transaction Report
Form 4
Simpson Robert Arthur
SVP/GM, Global Vascular
Transactions
- Award
Common Stock
2017-07-26+3,739→ 13,739 total - Award
Non-Qualified Stock Option (right to buy)
2017-07-26+13,137→ 13,137 totalExercise: $16.55From: 2018-07-26Exp: 2027-07-26→ Common Stock (13,137 underlying) - Award
Performance Right
2017-07-26+7,477→ 7,477 total→ Common Stock (7,477 underlying)
Footnotes (3)
- [F1]This acquisition of 3,739 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 3,739 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 26, 2018, such that 25% of the restricted stock units will vest on each of July 26, 2018, 2019, 2020 and 2021.
- [F2]These stock options vest in four equal annual installments beginning on July 26, 2018, such that 25% of the options will vest on each of July 26, 2018, 2019, 2020 and 2021.
- [F3]Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited.